# FibroBiologics, Inc. Common Stock (FBLG)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/FBLG/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -9.12M | $ -7.66M | $ 1.46M | $ 4.64M |
| 2025 | $ 0 | $ -19.09M | $ -17.05M | $ 2.41M | $ 6.16M |
| 2024 | $ 0 | $ -11.73M | $ -12.70M | $ 10.55M | $ 2.74M |
| 2023 | $ 0 | $ -17.82M | $ -7.46M | $ 1.75M | $ 1.25M |
| 2022 | $ 0 | $ -5.72M | $ -2.84M | $ 7.52M | $ -4.00M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.32 |
| Liabilities / Eq | 0.71 |
| Current Ratio | 2.64 |

## Other views

- [Metrics](https://sponda.capital/en/FBLG.md)
- [Charts](https://sponda.capital/en/FBLG/charts.md)
- [Compare](https://sponda.capital/en/FBLG/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.